Monoclonal Antibodies Poised for Growth


This article, excerpted from Cambridge Health Institute’s CHA Life Science Report, discusses the tremendous growth expected for monoclonal antibodies, and how manufacturers are improving the quality of MAb-based products.


Author: Cambridge Health Institute

Find more white papers on Process OperationsIndustry Developments

View all white papers»